Fundacion de Estudios Clinicos

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis3 trials

Phase

• Phase 32 trials
• Phase 2/31 trial

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• Janssen Research & Development, LLC1 trial

Running trials

• Active, not recruiting

  A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT04033445· Phase 2/3· Janssen Research & Development, LLC· Source

Closed trials

• Completed

  A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT03524092· Phase 3· Eli Lilly and Company· Source

• Completed

  An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

  NCT03518086· Phase 3· Eli Lilly and Company· Source